Devyser Diagnostics AB (publ) (DVYSR.ST) Financials

DVYSR.ST Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 470.1 million 112.2 million
Dec. 31, 2025 469.7 million 115.4 million
Sept. 30, 2025 459.9 million 119.0 million
June 30, 2025 461.1 million 123.1 million

DVYSR.ST Free Cash Flow and Stock based compensation

No data available :(

DVYSR.ST Net Income

No data available :(

DVYSR.ST Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 75.3 million 300000 35.0 million
Dec. 31, 2025 77.5 million 37.8 million 37.5 million
Sept. 30, 2025 84.9 million 300000 38.4 million
June 30, 2025 100.4 million 300000 53.8 million

DVYSR.ST Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 16.7 million
Dec. 31, 2025 16.7 million
Sept. 30, 2025 16.6 million
June 30, 2025 16.6 million

DVYSR.ST Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 300000 5.4 million 42.3 million -
Dec. 31, 2025 15.6 million 2.4 million 36.6 million -
Sept. 30, 2025 800000 3.5 million 37.4 million -
June 30, 2025 17.6 million 5.0 million 46.2 million 31.9 million

DVYSR.ST Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 61.8 million 11.3 million
Dec. 31, 2025 72.0 million 14.8 million
Sept. 30, 2025 56.4 million 14.1 million
June 30, 2025 67.4 million 10.6 million

DVYSR.ST

Price: SEK92.20

52 week price:
74.00
159.60

Earnings Per Share: 0.90 SEK

P/E Ratio: 104.44

Exchange: STO

Sector: Healthcare

Industry: Diagnostics & Research

Market Capitalization: 1.6 billion

Links: